Aspira Pathlab & Diagnostics Ltd approves allotment of shares, NCRPS

The Operation committee of Directors of Aspira Pathlab & Diagnostics Ltd at its meeting held on August24,2018 at 12PM has approved the allotment of 30,00,000 (Thirty Lakh) equity Shares of Rs. 10/- (Rupees Ten) each for cash at a price of Rs. 17 /- (Rupees Seventeen only) per share (including a premium of Rs. 7/- per share), the price has been calculated in accordance with the SEBI (ICDR) Regulations, 2009, aggregating to Rs. 5,10,00,000/- (Rupees Five Crores Ten Lakhs) on preferential basis to Promoters / Promoter Groups and Strategic Investors not forming part of Promoters Group of the Company.

The board also approved the allotment of 55,00,000 (Fifty-FiveLakhs) 9% Non-Convertible, Non-Cumulative, Non-Participating, Redeemable Preference Shares (NCRPS) of the face value of Rs. 10 each on private placement basis to Yashraj Biotechnology Limited, Promoter of the Company for conversion of loan. The said preference shares are not proposed to listed on any stock exchange.

Source : Equity Bulls

Keywords